MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 102 filers reported holding MAXCYTE INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,476,635 | -29.3% | 1,434,819 | +4.1% | 0.34% | -22.0% |
| Q2 2023 | $6,327,535 | +7.5% | 1,378,548 | +15.9% | 0.43% | +20.3% |
| Q1 2023 | $5,887,946 | -9.5% | 1,189,484 | -0.2% | 0.36% | -6.8% |
| Q4 2022 | $6,507,255 | -17.0% | 1,191,805 | -1.2% | 0.38% | -20.0% |
| Q3 2022 | $7,839,000 | +40.2% | 1,206,013 | +2.0% | 0.48% | +38.6% |
| Q2 2022 | $5,591,000 | +59.4% | 1,182,016 | +135.6% | 0.35% | +109.0% |
| Q1 2022 | $3,508,000 | +42.6% | 501,811 | +107.9% | 0.17% | +48.2% |
| Q4 2021 | $2,460,000 | +30.0% | 241,377 | +55.8% | 0.11% | +25.8% |
| Q3 2021 | $1,892,000 | – | 154,925 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NORTH RUN CAPITAL, LP | 480,900 | $3,361,000 | 4.94% |
| Casdin Capital, LLC | 13,971,334 | $97,660,000 | 4.38% |
| Vitruvian Partners LLP | 4,385,670 | $30,656,000 | 3.25% |
| RIVER GLOBAL INVESTORS LLP | 2,100,000 | $14,849,000 | 1.95% |
| APIS CAPITAL ADVISORS, LLC | 180,000 | $1,258,000 | 1.52% |
| Pier Capital, LLC | 1,017,753 | $7,114,000 | 0.91% |
| First Light Asset Management, LLC | 1,321,406 | $9,237,000 | 0.82% |
| Montanaro Asset Management Ltd | 929,000 | $6,557,000 | 0.81% |
| Nicholas Investment Partners, LP | 776,963 | $5,431,000 | 0.39% |
| Bleichroeder LP | 250,000 | $1,764,000 | 0.31% |